MissionIR Articles
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly…
-
MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) Releases Update on Company Operations, Explorations
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has shared an overview of its operations. The update includes information regarding EXN’s Platosa project as well as other upcoming exploration plans; the company stated that additional…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)
The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries –…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency
Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”)…
-
MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Continues ‘Recipe for Success’ to Expand into Additional Market Segments
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently announced the expansion of its e-commerce platform to the United Kingdom. The new platform, www.PlantX.uk, will offer customers a similar experience as PlantX’s customers in…
-
SRAX Inc. (NASDAQ: SRAX) Set to Benefit as Analysts Hike Company’s Fourth Quarter Revenue Forecasts
Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth SRAX’s…
-
Amid Climate Change and National Food Security Concerns, PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Pursues Status as Plant-based Lifestyle Education Hub
PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective use and wellness benefits The company has developed a weekly podcast series, YouTube channel videos…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Releases Dates for 2022 Virtual Conferences
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time
As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem.…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Support Low-Cost/No-Cost Psychedelic Clinic for Underserved Communities
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones to revolutionize mental health care. Among these, the company recently secured a grant for the first-ever…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Marks True Milestone in Development, Growth
Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, recently completed the initial shipment of its sugarBEAT(R) continuous glucose monitor (“CGM”)…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Engagement of Skyline Corporate Communications Group LLC for IR Services
FingerMotion (NASDAQ: FNGR), a mobile data and services company with evolving technology and a core competency in mobile payment and recharge platform solutions in China, today announced that it has recently retained the services of…
-
MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Proprietary Medical Device Passes Registration Tests, Slated to Start Clinical Trial
AnPac Bio-Medical Science (NASDAQ: ANPC), a U.S.- and China-based biotechnology company focused on early cancer screening and detection, announced that its Class III medical device for lung cancer auxiliary diagnosis has passed stringent and rigorous…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Foray into Mexico, Showcased in Latest Episode of ‘Bell2Bell’ Podcast
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products, today announced that its Mind Naturals skincare brand has launched sales through Walmart.com and Coppel, a nationwide department store in Mexico. According…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Milestone Notice of Allowance for Revolutionary Treatment of Anxiety Disorders
USPTO notice marks important milestone in the expansion of CYBN’s intellectual property portfolio Once issued, patent may have opportunity to cover a broad range of claims Anxiety disorders are one of the most common mental…
-
MissionIRNewsBreaks – Why Growth Capital Acquisition Corp. (NASDAQ: GCAC) Is ‘One to Watch’
Growth Capital (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on Feb. 2, 2021, recently announced its entry into a definitive business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and…
-
Flora Growth Corp. (NASDAQ: FLGC) Entering 2022 with Momentum from Sustainability Efforts and the Building of Global Distribution Channels
Flora Growth Corp. is a Canadian cannabis and wellness brand distributor operating from a cultivation base in central Colombia The company’s focus on sustainability guides its efforts to market products that are beneficial to their…
-
FingerMotion Inc. (NASDAQ: FNGR) Becomes the Latest Tech Company Listed on the NASDAQ Capital Market
FingerMotion received approval for its application for NASDAQ up-listing, and commenced trading on Tuesday, December 28, 2021, under the company’s current trading symbol, “FNGR” The approval marks a key milestone for the company as it…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Optimizes Capital Strategy with Strategic Buyback
- Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Sets First Quarter 2026 Earnings Call For May 15
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Enters LOI to Acquire CyberCatch
- MissionIRNewsBreaks – Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Targets Precision Cardiology with Multi-Omic AI Platform